KATHERINE CROSS: Open Payments
NPI 1225493091 · KNOXVILLE, TN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$4,321 in 199 payments from 21 companies in 2025. Trend: 2023 $0 · 2024 $1,049 · 2025 $4,321
Food & beverage: $4,223Education: $98
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP | 32 | $794 |
| GlaxoSmithKline, LLC. | 38 | $620 |
| GENZYME CORPORATION | 17 | $345 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 9 | $297 |
| Verona Pharma, Inc. | 17 | $272 |
| Grifols USA, LLC | 10 | $265 |
| Actelion Pharmaceuticals US, Inc. | 9 | $248 |
| Insmed, Inc. | 12 | $243 |
| Regeneron Healthcare Solutions, Inc. | 8 | $213 |
| Viatris Specialty LLC | 14 | $173 |
Products named: DUPIXENT, NUCALA, TEZSPIRE, Ohtuvayre, Prolastin-C Liquid, OPSUMIT, Arikayce, BREZTRI.
Industry payments across TN — which companies pay providers there.
